Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Magnolia Neurosciences
4835
Magnolia Neurosciences
Health Care
Medical
Technology
Biotechnology
Magnolia NeuroSciences discovers and develops drug-like small molecule therapeutics for the prevention of neuronal cell death.
Suggest edits
Raised
$62M
Follow us
Also headquartered in New York
Verizon
IBM
HBO
Bloomberg
Goldman Sachs
Kickstarter
JPMorgan
Wired
The New York Times
Morgan Stanley
Companies in the same industry
Attentive Therapeutics
Cambridge Cancer Genomics
AZTherapies
UniQure
molecular assemblies
Immortagen
Addex Therapeutics
AnchorDX
Inotrem
HitGen
Alexa global traffic share
Overview
Funding
2
Add info
Latest funding
$31,000,000
Venture capital (Series A) - 2018
Partnership Fund for New York City
ARCH Venture Partners
L.P.
+9
$31,000,000
Venture capital (Series A) - 2018
MD Anderson Cancer Center
Accelerator Life Science Partners
Team Size
1–10
Employees
I work here
Location
New York
,
United States
Headquarters
Explore New York
$31,000,000
Venture capital (Series A)
FinSMEs
Magnolia Neurosciences Raises $31M in Series A Funding
Funding
Science
